Fungal immunomodulatory protein-fve could modulate airway remodel through by affect IL17 cytokine
Background: Asthma is one of the most common allergic diseases. Our previous studies have reported that FIP-fve in acute allergic mouse model can reduce inflammation, improve the balance of the Th1/Th2 system. However, the effects of reducing airway remodeling on FIP-fve is still unknown. Objective:...
Main Authors: | Yu-Tzu Lee, Chia-Ta Wu, Hai-Lun Sun, Jiunn-Liang Ko, Ko-Haung Lue |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-10-01
|
Series: | Journal of Microbiology, Immunology and Infection |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1684118217301214 |
Similar Items
-
Bioaccessibility Study for Fungal Immunomodulatory Protein FIP-fve
by: Yu-Ling Liu, et al.
Published: (2013) -
Studies on the mechanism of the fungal immunomodulatory protein, FIP-fve
by: Sai-Wen Tang, et al.
Published: (2003) -
Effect of FIP-fve on airway inflammation and remodeling in mouse asthma model
by: Yu-Tzu Lee, et al.
Published: (2018) -
Eosinophil Apoptosis Induced by Fungal Immunomodulatory Peptide-fve via Reducing IL-5α Receptor
by: Chia-Wei Hsieh, et al.
Published: (2007-01-01) -
Establishment of Quality Control Indicator and Bioaccessibility Evaluation for Fungal Immunomodulatory Protein FIP-fve
by: Wei-Chi Chen, et al.
Published: (2015)